Common questions about Постинор (FAQ)
Q: Is it possible to take Постинор if I am breastfeeding?
Regulatory documents state that the active substance, levonorgestrel, passes into breast milk. While the overall risk to the infant is considered low, official guidance describes a recommendation to take the tablet immediately after a feeding and to use an alternative method to feed the infant for at least 8 hours after administration.
Q: What is the difference between Постинор and a medical abortion pill?
Постинор is classified as an emergency contraceptive and is intended only to prevent pregnancy, primarily by preventing or delaying ovulation. Official product information strictly states that it is contraindicated and will not interrupt an established pregnancy, which is the function of a medical abortion pill.
Q: What is the mechanism of action of the active component?
The drug's primary action is described as the inhibition or delay of the body's release of the egg (ovulation) by suppressing certain hormones. Regulatory information also indicates that it may temporarily alter the cervical mucus, which can impede sperm movement.
Q: Is Постинор considered a reliable method of contraception when used regularly?
No. Official guidance clearly states that this medicine is an occasional method for use in an emergency situation. It is not intended for use as a primary or ongoing method of routine contraception.
Q: What are the common misunderstandings about how Постинор works?
A key point highlighted in official documentation is that this emergency contraceptive works by targeting pre-fertilization events, such as blocking ovulation. It is strictly contraindicated if a woman is already pregnant, as it cannot interrupt an existing pregnancy.
Q: What does the patient leaflet say about overdose?
Regulatory documents state that no serious harmful effects have been reported following an acute overdose of the active ingredient. Patients who receive more than the recommended dose may experience side effects such as nausea and withdrawal bleeding.
Q: What are the documented infrequent but serious side effects?
The regulatory safety profile notes that if the medication fails to prevent conception, there is a risk of ectopic pregnancy (a pregnancy outside the uterus); such an event is a critical safety consideration noted in official labeling. Very rare, post-marketing reports of thromboembolic events (blood clots) are also documented.
Q: Is Постинор the same as other 'morning after' pills?
Постинор is a specific brand name for an emergency contraceptive that uses the active ingredient levonorgestrel. This is one type of 'morning after' pill. Other emergency contraceptive pills, such as those containing ulipristal acetate, have different active ingredients and may have different administration guidelines.
Q: Can Постинор be purchased without a prescription in some countries?
The regulatory status and accessibility of levonorgestrel-based emergency contraception vary significantly by country. In many regions, the product is available to all ages over the counter (OTC) without the need for a prescription.
Q: Is it normal to experience nausea after taking Постинор?
Yes. Nausea is classified in official regulatory documents as a very common side effect. This means it is among the side effects most frequently reported by patients and may occur in 1 in 10 or more patients.
Q: Can taking Постинор affect future fertility?
Official data and regulatory documents do not suggest a long-term effect on future fertility after using this medicine. The rapid return of normal fertility is the reason regulatory information emphasizes the need for reliable regular contraception.
Q: What age groups is Постинор generally considered appropriate for?
The medication is indicated for use by adults and adolescents who have begun menstruating. Official guidance generally supports its use from the age of 16 and above, but local laws determine the exact age of availability and necessity for medical supervision.
Q: How long does the drug stay in the body after taking it?
Regulatory pharmacokinetic data shows the active substance, levonorgestrel, has a half-life of approximately 26 to 28 hours. The half-life is the time it takes for the amount of drug in the body to be reduced by half.
Q: Can the drug be used if someone is already taking hormonal birth control?
Yes. Regulatory labeling states that taking this emergency contraceptive does not typically contraindicate the continuation of a patient’s regular hormonal birth control method.
Q: What are the signs that Постинор may not have worked?
Official guidance advises performing a pregnancy test if the next menstrual period is delayed by more than seven days past the expected start date. A period that is unusually light or heavy compared to normal may also warrant testing.
Q: Does body weight influence how effective Постинор is described to be?
Regulatory documents include a warning that limited and inconclusive data suggest a possible reduction in effectiveness in women who have a high body weight or Body Mass Index (BMI).
Q: Can alcohol consumption interact with Постинор?
Official regulatory documents do not list alcohol as a substance that reduces the efficacy of the drug. However, alcohol consumption may potentially worsen common central nervous system side effects like nausea or dizziness.
Q: Can people with liver conditions use Постинор?
The medication is not recommended for patients who have severe hepatic dysfunction (severe liver problems). This restriction is in place because the body’s ability to process and clear the active ingredient may be significantly impaired.
Q: Does the time of day a person takes Постинор matter?
No. Official administration instructions state that the tablet can be used at any time during the menstrual cycle. The critical factor emphasized is taking it as soon as possible after the event of unprotected intercourse.
Q: Is the medication known to interact with herbal supplements?
Yes. The herbal product St. John's Wort (Hypericum perforatum) is explicitly listed in official documents as a substance that can reduce the effectiveness of the medicine by speeding up its breakdown in the body.
Q: What is the general duration of action of the active ingredient?
The drug's action is primarily an acute, short-term effect concentrated in the period immediately following administration to prevent or delay ovulation. The half-life of the substance is about 26 to 28 hours, but the critical window for its contraceptive effect is much shorter.
Q: How does Постинор affect the uterine lining?
Official documents indicate that a secondary mechanism involves the temporary alteration of the endometrium (the uterine lining). This change is intended to support the medication’s primary role as a preventive measure targeting pre-fertilization events.
Q: Is there any research on long-term effects of occasional use of Постинор?
Regulatory guidance stresses that the drug is for a single emergency intervention. Consequently, available research primarily focuses on short-term outcomes, and there is limited information regarding potential long-term health implications after a single or infrequent use.
Q: Can a person be allergic to any component in Постинор?
Yes. The medicine is contraindicated for women with a known hypersensitivity (allergy) to the active substance, levonorgestrel, or to any of the non-active components (excipients), such as lactose.
Q: Does Постинор interact with medications for epilepsy?
Yes. Certain anticonvulsant medications, such as phenytoin, phenobarbital, and carbamazepine, are explicitly listed in regulatory documents. These drugs can significantly reduce the effectiveness of the medicine by accelerating its breakdown.
Q: Can a person experience fatigue after taking Постинор?
Yes. Fatigue is listed in official regulatory documents as a very common side effect. This means it is a frequently reported experience among patients using the medication.
Q: Are there specific diet restrictions when taking Постинор?
No. Official administration instructions state that the tablet may be taken with or without food, indicating that specific diet restrictions are not required.
Q: Can taking other medications at the same time make the side effects of Постинор worse?
Regulatory warnings primarily focus on interactions that reduce efficacy. The label explicitly notes the potential for levonorgestrel to increase the toxicity of one specific drug, cyclosporin, by inhibiting its metabolism, but generally does not address the potentiation of its own side effects.
Q: What is the half-life of the active substance in Постинор?
Regulatory pharmacokinetic data states that the half-life (the time required for half the dose to be eliminated from the body) of the active substance, levonorgestrel, is approximately 26 to 28 hours.
Q: Is there a maximum number of times someone can use Постинор per year according to guidelines?
Official guidance stresses that the drug is an occasional method and not intended for routine use. However, regulatory documents do not specify an absolute maximum number of times it can be used per year.
Q: Can people with gastrointestinal conditions use Постинор?
The medication is not recommended for patients with severe malabsorption syndromes, such as Crohn's disease. This is because severe malabsorption may compromise the uptake of the drug, leading to reduced effectiveness.
Q: Is Постинор known to be effective if taken near ovulation?
The drug's primary mechanism is to inhibit or delay ovulation. Regulatory documents indicate that the mechanism is maximally effective when administered before the body's natural ovulation trigger begins and is overridden if administered after that trigger has peaked.
